Are ultraprocessed foods putting your child’s heart at risk?

While bio­phar­ma com­pa­nies are call­ing foul over the fact that block­buster drugs with mul­ti­ple or­phan des­ig­na­tions re­main el­i­gi­ble for gov­ern­ment price ne­go­ti­a­tions un­der the In­fla­tion

The FDA is strength­en­ing its fo­cus on us­ing math­e­mat­i­cal sim­u­la­tion and mod­el­ing to guide drug de­vel­op­ment with a new cen­ter of ex­cel­lence housed in the